{
    "nct_id": "NCT06159842",
    "official_title": "An Investigator Initiated Study to Evaluate the Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution (Levulan® Kerastick®) (ALA) + Blue Light in the Treatment of Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)",
    "inclusion_criteria": "* Must be an adult (18 years of age or older)\n* Voluntary written consent required\n* Must have a recently diagnosed (no more than six months from first study visit) facial isSCC lesion that meets surgery excision size requirements\n* Cannot have other dermatological disease in the isSCC target area\n* Must be willing to follow study instructions and complete study requirements, including not using non-approved lotions and creams on the treatments areas\n* If female, cannot be pregnant before and during the study and agree to use acceptable forms of birth control\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Sensitive to any of the study treatment ingredients\n* Pregnant or lactating\n* Medical laboratory evidence of other non-isSCC tumor in the target lesion biopsy specimen\n* History of recurrence in the target isSCC lesion\n* Medical laboratory evidence of certain growth patterns in the target lesion biopsy specimen\n* Chronic medical condition that in the Investigators opinion will interfere in the trial or affect participant safety",
    "miscellaneous_criteria": ""
}